A population-based study of follow-up care for Hodgkin lymphoma survivors: Opportunities to improve surveillance for relapse and late effects

Cancer

Volumn 116, Issue 14, 2010, Pages 3417-3425

  Hodgson, David C ^a,b,c   Grunfeld, Eva ^a,b,d   Gunraj, Nadia ^c   Del Giudice, Lisa ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

Cancer screening; Cancer survivor; Follow up; Hodgkin lymphoma; Imaging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVOR; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX RADIOGRAPHY; UTERINE CERVIX CANCER;

ADULT; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; ONTARIO; POPULATION SURVEILLANCE; QUALITY OF HEALTH CARE; RECURRENCE; SURVIVORS;

EID: 77954935245     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25053     Document Type: Article

References (38)

1. Hudson MM, Mulrooney DA, Bowers DC, et al. High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. J Clin Oncol. 2009;27:2405-2414.
2. Ralleigh G, Given-Wilson R. Breast cancer risk and possible screening strategies for young women following supradiaphragmatic irradiation for Hodgkin's disease. Clin Radiol. 2004;59:647-650.
3. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89. (Pubitemid 46535708)
4. Children's Oncology Group (COG). COG website. Available at: www.survivorshipguidelines.org; 2008. Accessed July 22, 2009.
5. Acharya S, Sarafoglou K, LaQuaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer. 2003;97:2397-2403.
6. Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004;22:3139-3148.
7. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878-1886.
8. Bhatia S, Yasui Y, Robison LL, et al. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol. 2003;21:4386-4394.
9. Hodgson DC, MacKenzie R, Forde N, et al. Increased risk of clinically significant cardiac toxicity following modern treatment for Hodgkin's Disease. Eur J Haematol. 2004;73:21.
10. Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99:206-214.
11. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol. 1994;12:312-325.
12. Jost L. Hodgkin's disease: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2007;18(suppl 2):ii53-ii54.
13. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines: Hodgkin Disease/Lymphoma, version 2. Fort Washington, Pa: NCCN; 2009.
14. Ng AK, Li S, Recklitis C, et al. Health practice in long-term survivors of Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2008;71:468-476.
15. Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008;26:4401-4409.
16. Oeffinger KC, Ford JS, Moskowitz CS, et al. Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer. JAMA. 2009;301:404-414.
17. Snyder CF, Earle CC, Herbert RJ, et al. Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med. 2008;23:254-259.
18. Snyder CF, Frick KD, Kantsiper ME, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27:1054-1061.
19. Jaakkimainen L, Upshur R, Klein-Geltink J, et al, eds. Primary Care in Ontario: ICES Atlas. Toronto, Ontario: Institute for Clinical Evaluative Sciences; 2006.
20. [No authors listed] NCCN practice guidelines for Hodgkin's disease. National Comprehensive Cancer Network. Oncology (Williston Park). 1999;13:78-110.
21. Hodgson DC, Pintilie M, Yun L, et al. Cardiovascular morbidity following modern treatment for Hodgkin lymphoma: age- and sex-specific estimates of risk in the doxorubicin era. Int J Radiat Oncol Biol Phys. 2008;72:S122-S123.
22. Myrehaug S, Pintilie M, Tsang R, et al. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma. 2008;49:1486-1493.
23. Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007;25:1489-1497.
24. Torrey MJ, Poen JC, Hoppe RT. Detection of relapse in early-stage Hodgkin's disease: role of routine follow-up studies. J Clin Oncol. 1997;15:1123-1130.
25. Radford JA, Eardley A, Woodman C, et al. Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records. BMJ. 1997;314:343-346. (Pubitemid 27056556)
26. Dryver ET, Jernstrom H, Tompkins K, et al. Follow-up of patients with Hodgkin's disease following curative treatment: the routine CT scan is of little value. Br J Cancer. 2003;89:482-486.
27. Guadagnolo BA, Punglia RS, Kuntz KM, et al. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease. J Clin Oncol. 2006;24:4116-4122.
28. Laupacis A, Przybysz R, Anne Keller A. CT and MRI scanning. In: Tu J,Pinfold S, McColgan P, et al, eds. Access to Health Services in Ontario, 2nd ed. Toronto, Ontario: Institute for Clinical Evaluative Sciences; 2006.
29. Cancer Care Ontario. Cancer Quality Council of Ontario: Cancer Care Ontario, 2008. Available at: http://www. cancercare.on.ca/cms/One.aspx?portalId= 14473&pageId=14840. Accessed July 22, 2009.
30. Ng AK, Bernardo MV, Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989-1996.
31. Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006;24:848-855.
32. Oeffinger KC, Wallace WH. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer. 2006;46:135-142.
33. Hutchings M, Eigtved AI, Specht L. FDG-PET in the clinical management of Hodgkin lymphoma. Crit Rev Oncol Hematol. 2004;52:19-32.
34. Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2006;47:1326-1334.
35. Raanani P, Shasha Y, Perry C, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol. 2006;17:117-122.
36. Rigacci L, Castagnoli A, Dini C, et al. FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results. Oncol Rep. 2005;14:1209-1214.
37. Oeffinger KC, McCabe MS. Models for delivering survivorship care. J Clin Oncol. 2006;24:5117-5124.
38. Oeffinger KC, Robison LL. Childhood cancer survivors, late effects, and a new model for understanding survivorship. JAMA. 2007;297:2762-2764.